Month: October 2022
Artificial Sweeteners and possible risk of heart disease and/or stroke
A new study published in BMJ (British Medical Journal) has raised the question of artificial sweeteners and its possible association with heart diseases and/or stroke….
Integrative Medicine – Improving the quality of life
An integrative medicine helps to alleviate the symptoms of various diseases. It’s focus is more of a healing oriented, and works in multiple dimensions including…
Immunotherapy before surgery (Neoadjuvant pembrolizumab) in Melanoma patients
This was studied in a phase 2 study, in patients with stage III or IV resectable melanoma patients. The results were presented at ESMO 2022…
An important class of cancer drugs – Antibody Drug Conjugates (ADCs)
The antibody drug conjugates are a new class of drugs in the filed of Cancer Medicine. They are also called as ADCs. It is an…
New treatment Futibatinib (Lytgobi) approved for intrahepatic cholangiocarcinoma
Cholangiocarcinomas are bile duct cancers. The bile ducts are thin ducts or tubes that go from liver and gall bladder to the small intestine. The…
Renal Cell Carcinoma – new triplet treatment beat doublet in Progression Free Survival (PFS)
Kidney Cancer or Renal Cell Carcinoma treatment has been evolving. The new study COSMIC-313 presented the data of three drug combination Cabozantinib, Nivolumab and ipilimumab….